Philips Sterilizable Defibrillator Paddles, Switched Internal Paddles, Model Numbers M4741A, M474...

FDA Device Recall #Z-0284-2021 — Class II — September 14, 2020

Recall Summary

Recall Number Z-0284-2021
Classification Class II — Moderate risk
Date Initiated September 14, 2020
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Philips North America, LLC
Location Andover, MA
Product Type Devices
Quantity 8,942

Product Description

Philips Sterilizable Defibrillator Paddles, Switched Internal Paddles, Model Numbers M4741A, M4742A, M4743A, M4744A - Product Usage: used in pairs to transmit a controlled electrical shock from an external defibrillator directly to the exposed heart muscle of a post-pubescent patient in order to intentionally stop start the heartbeat during cardiopulmonary surgery.

Reason for Recall

The periodic Paddle Checks recommended in the Instructions for Use for Sterilizable Defibrillator Paddles may not detect one failure mode for the Switched Internal Defibrillator Paddles. Philips has created an addendum to the IFU, that includes a test for the switched paddles only, which will detect this failure mode.

Distribution Pattern

Global Distribution. US Nationwide.

Lot / Code Information

All units manufactured and distributed January 2015 to August 2020.

Other Recalls from Philips North America, LLC

Recall # Classification Product Date
Z-0926-2022 Class II The IFU for the Autoclavable Temperature Probes... Feb 7, 2022
Z-1326-2021 Class II Philips SureSigns VM4, VM6 and VM8 - Product Us... Mar 23, 2021
Z-0852-2021 Class II Emission Computed Tomography System Image Proce... Nov 19, 2020
Z-0285-2021 Class II Philips Sterilizable Defibrillator Paddles, Swi... Sep 14, 2020
Z-2794-2020 Class II Philips HeartStart MRx, Monitor/Defibrillators ... Jul 16, 2020

Frequently Asked Questions

Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately — you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.